NCT06728007 Nephrological Outcome and Associated Congenital Anomalies in Pediatric Patients with Horseshoe Kidney
| NCT ID | NCT06728007 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Horseshoe Kidney |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2025-06-01 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A retrospective, observational multicentre trial on the nephrological outcome and associated congenital anomalies in children with Horseshoe Kidney.
Eligibility Criteria
Inclusion Criteria: * Patients with confirmed ultrasound and/or scintigraphic diagnosis of horseshoe kidney; * Patients with an age at first assessment of between 0 and 18 years; * Obtaining written Informed consent. Exclusion Criteria: * Patients with a definitive diagnosis of another form of CAKUT during the diagnostic pathway.
Contact & Investigator
Claudio La Scola, MD, PhD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06728007 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Horseshoe Kidney. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06728007 currently recruiting?
Yes, NCT06728007 is actively recruiting participants. Contact the research team at claudio.lascola@aosp.bo.it for enrollment information.
Where is the NCT06728007 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06728007 clinical trial?
NCT06728007 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Claudio La Scola, MD, PhD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.